Regulatory T cells (Tregs) are a vital sub‐population of CD4+ T cells with major roles in immune tolerance and homeostasis. Given such properties, the use of regulatory T cells for immunotherapies has been extensively investigated, with a focus on adoptive transfer of ex vivo expanded natural Tregs (nTregs). For immunotherapies, induced Tregs (iTregs), generated in vitro from naïve CD4+ T cells, provide an attractive alternative, given the ease of generating cell numbers required for clinical dosage. While the combination of TGF‐β, ATRA and rapamycin has been shown to generate highly suppressive iTregs, the challenge for therapeutic iTreg generation has been their instability. Here, we investigate the impact of rapamycin concentrations and α‐CD3/CD28 bead ratios on human iTreg stability.
Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cells
Juewan Kim,C. Hope,G. Perkins,Sebastian O Stead,Jacqueline C. Scaffidi,Francis D. Kette,R. Carroll,S. Barry,P. Coates
Published 2020 in Clinical & Translational Immunology
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Clinical & Translational Immunology
- Publication date
2020-12-14
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-96 of 96 references · Page 1 of 1
CITED BY
Showing 1-9 of 9 citing papers · Page 1 of 1